Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- Tony S.K. Mok
- , Yi Long Wu
- , Iveta Kudaba
- , Dariusz M. Kowalski
- , Byoung Chul Cho
- , Hande Z. Turna
- , Gilberto Castro
- , Vichien Srimuninnimit
- , Konstantin K. Laktionov
- , Igor Bondarenko
- , Kaoru Kubota
- , Gregory M. Lubiniecki
- , Jin Zhang
- , Debra Kush
- , Gilberto Lopes
- , Gonzalo Gomez Aubin
- , Luis Fein
- , Diego Kaen
- , Ruben Kowalyszyn
- , Guillermo Lerzo
Research output: Contribution to journal › Article › peer-review
3178
Link opens in a new tab
Citations
(Scopus)